• Tenaya Therapeutics granted stock options for 1,650,000 shares to newly appointed CFO Eric Hyllengren.
• Two new non-executive employees received options covering 187,200 shares in aggregate.
• Options priced at USD 0.84 per share, matching the July 13, 2026 close.
• Ten-year term; vesting over four years with 25% after one year, then monthly thereafter.
• Awards issued under the 2024 Inducement Equity Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to generate this news brief on July 14, 2026, and is solely responsible for the information contained therein.